Stocks / NASDAQ / Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc.

Industry:   Health Care - Biotechnology: Commercial Physical & Biological Resarch Stock Symbol:   PIRS - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Pieris Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their biopharmaceutical products.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The data presented September 10, 2015 at the American Society for Microbiology (ASM) Conference on Pseudomonas in Washington, DC, by Dr. Carsten Corvey, Global Sanofi Project leader, provided an overview of the drug-like properties of this complex protein, as well as promising in vivo activity in a chronic Pseudomonas aeruginosa infection animal model.” Read the following article

Company Description

Pieris Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. It offers technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. [Source: MarketWatch]

Company Website: http://www.pieris.com

Contact:   http://www.pieris.com/contact; IR: thoffman@troutgroup.com;